B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Signaling by cytosolic FGFR1 fusion mutants

REACTOME PATHWAY
Reactome: R-HSA-18391176 genes24 compounds

The Signaling by cytosolic FGFR1 fusion mutants pathway (Reactome ID: R-HSA-1839117) involves 6 genes and is affected by 24 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

BCRGRB2PIK3R1STAT1STAT3STAT5A

Compounds Affecting Signaling by cytosolic FGFR1 fusion mutants

#CompoundTargets HitStudies
1Sorafenib300
2Axitinib298
319-((1'S,4'R)-4'-hydroxy-1'-methoxy-2'-oxopentyl)geldanamycin [Supplementary Concept]300
4triolimus [Supplementary Concept]33
5pterostilbene299
6Crizotinib298
7Imatinib Mesylate300
8pictilisib25
9Wortmannin300
10ly29400211
11alpelisib227
12Sirolimus300
13torin 110
14Quercetin300
15Budesonide1,000
16Methylene Blue200
17egcg300
18Flurandrenolone65
19Hexachlorophene300
20streptonigrin299
21Niclosamide299
22Fingolimod Hydrochloride56
23Celecoxib295
24Dactinomycin297

About the Signaling by cytosolic FGFR1 fusion mutants Pathway

The Signaling by cytosolic FGFR1 fusion mutants pathway is catalogued in Reactome (ID: R-HSA-1839117) and involves 6 genes. In the BiohacksAI corpus, 24 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include BCR, GRB2, PIK3R1, STAT1, STAT3.